[HTML][HTML] Combination therapy in the treatment of hypertension

C Guerrero-García, AF Rubio-Guerra - Drugs in context, 2018 - ncbi.nlm.nih.gov
Hypertension is a major preventable risk factor for atherosclerosis and ischemic heart
disease. Although modern and effective antihypertensive drugs are available, most patients …

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group

LA Leiter, DH Fitchett, RE Gilbert, M Gupta… - Canadian Journal of …, 2011 - Elsevier
The concepts of “cardiometabolic risk,”“metabolic syndrome,” and “risk stratification” overlap
and relate to the atherogenic process and development of type 2 diabetes. There is …

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …

G Mancia, G De Backer, A Dominiczak… - European heart …, 2007 - academic.oup.com
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

G Mancia, S Laurent, E Agabiti-Rosei… - Blood …, 2009 - Taylor & Francis
GIUSEPPE MANCIAa, STÉPHANE LAURENTb, ENRICO AGABITI-ROSEIc, ETTORE
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

WJ Elliott, PM Meyer - The Lancet, 2007 - thelancet.com
Background The effect of different classes of antihypertensive drugs on incident diabetes
mellitus is controversial because traditional meta-analyses are hindered by heterogeneity …

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group …

MJ Brown, B Williams, SV Morant, DJ Webb… - The lancet Diabetes & …, 2016 - thelancet.com
Background Potassium depletion by thiazide diuretics is associated with a rise in blood
glucose. We assessed whether addition or substitution of a potassium-sparing diuretic …

Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society clinical practice guideline

JL Rosenzweig, GL Bakris, LF Berglund… - The Journal of …, 2019 - academic.oup.com
Objective To develop clinical practice guidelines for the primary prevention of atherosclerotic
cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at …

The metabolic syndrome in hypertension: European society of hypertension position statement

J Redon, R Cifkova, S Laurent, P Nilsson… - Journal of …, 2008 - journals.lww.com
The metabolic syndrome considerably increases the risk of cardiovascular and renal events
in hypertension. It has been associated with a wide range of classical and new …

Risk/benefit assessment of β-blockers and diuretics precludes their use for first-line therapy in hypertension

FH Messerli, S Bangalore, S Julius - Circulation, 2008 - Am Heart Assoc
2691 levels, showed that treatment significantly reduced nonfatal myocardial infarction (MI)
or CHD death (major CHD) by 14%, which represented approximately two thirds of the …

[PDF][PDF] 2007 Guidelines for the management of arterial hypertension

R De Caterina, V Dean, K Dickstein, G Filippatos… - European Heart …, 2007 - Citeseer
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …